NEW YORK, April 7, 2008 /PRNewswire/ -- Stronger than anticipated revenues for flu vaccines, and the surprising commercial success of Merck's Gardasil for HPV, which causes most cervical cancers, has led to a healthy $16.3 billion in vaccine sales in 2007. This represents an increase of 38% over 2006 sales of $11.7 billion, according to Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, a new market research study and reforecast of the vaccine market from Kalorama Information.
According to the report, new products approved in recent years, in particular Gardasil, but also RotaTeq, Pentacel, Zostavax and FluMist, are now having an impact on the market. These new products, combined with a continued emphasis on flu vaccines in the U.S. healthcare system, have created a healthy environment for vaccine products.
Five major players -- Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Wyeth and Novartis -- dominate vaccine sales. At these companies, as well as smaller producers, Kalorama Information has found increased interest in vaccines, and a willingness to look at products for conditions not historically addressed with vaccines, including diabetes, cancer and smoking cessation. Given this trend and strong sales, Kalorama Information expects vaccine sales to more than double in five years.
"You might call it a 'Gardasil Effect'," says Bruce Carlson, publisher of Kalorama Information. "R&D departments are more confident about investing in a vaccine product now than in the past because a strong marketing precedent has been established. Expect to see new vaccine products, and perhaps new companies in the market."
Kalorama Information's new report Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry reforecasts the market for this highly profitable drug segment and addresses the dramatic changes taking place. The report covers current world revenues and forecasts through 2013 for pediatric and adult vaccines, and provides pipeline analysis and company profiles. The report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Vaccines-Key-Players-1682234/.
About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. Kalorama routinely assists media with healthcare topics, and can provide experts to speak about markets in the life sciences industry. For more information, contact Andrea Hiller at 212-807-2673 or firstname.lastname@example.org, or visit http://www.kaloramaInformation.com.
|SOURCE Kalorama Information|
Copyright©2008 PR Newswire.
All rights reserved